Successfully funded companies were a mixed bag in 2014, with life science firms dominating the heap when it came to venture raises. And the capital effort had mixed results. While a $5.25 million fundraise propelled Durham technology firm Windsor Circle, with another $1 million added to the coffers a month later, a $10 million raise didn't stop Baxano Surgical from declaring bankruptcy in November. For some, the venture raise was only the beginning.